PERIMETER MEDICAL IMAGING AI (PINK.CA) Fundamental Analysis & Valuation

TSX-V:PINK • CA71385D1078

Current stock price

0.315 CAD
-0.04 (-11.27%)
Last:

This PINK.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PINK.CA Profitability Analysis

1.1 Basic Checks

  • In the past year PINK has reported negative net income.
  • PINK had a negative operating cash flow in the past year.
  • In the past 5 years PINK always reported negative net income.
  • In the past 5 years PINK always reported negative operating cash flow.
PINK.CA Yearly Net Income VS EBIT VS OCF VS FCFPINK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of PINK (-239.48%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -412.07%, PINK is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
ROA -239.48%
ROE -412.07%
ROIC N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
PINK.CA Yearly ROA, ROE, ROICPINK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • PINK has a Gross Margin (59.01%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of PINK has grown nicely.
  • PINK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
PINK.CA Yearly Profit, Operating, Gross MarginsPINK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. PINK.CA Health Analysis

2.1 Basic Checks

  • PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PINK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PINK.CA Yearly Shares OutstandingPINK.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PINK.CA Yearly Total Debt VS Total AssetsPINK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • PINK has an Altman-Z score of -23.73. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.
  • PINK has a Altman-Z score of -23.73. This is comparable to the rest of the industry: PINK outperforms 50.00% of its industry peers.
  • PINK has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.02, PINK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -23.73
ROIC/WACCN/A
WACC7.91%
PINK.CA Yearly LT Debt VS Equity VS FCFPINK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • PINK has a Current Ratio of 1.21. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.21, PINK is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • PINK has a Quick Ratio of 1.17. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.17, PINK belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.17
PINK.CA Yearly Current Assets VS Current LiabilitesPINK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. PINK.CA Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%141.95%

3.2 Future

  • Based on estimates for the next years, PINK will show a very strong growth in Earnings Per Share. The EPS will grow by 27.05% on average per year.
  • PINK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 96.55% yearly.
EPS Next Y47.91%
EPS Next 2Y27.54%
EPS Next 3Y29.05%
EPS Next 5Y27.05%
Revenue Next Year158.26%
Revenue Next 2Y147.5%
Revenue Next 3Y106.85%
Revenue Next 5Y96.55%

3.3 Evolution

PINK.CA Yearly Revenue VS EstimatesPINK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
PINK.CA Yearly EPS VS EstimatesPINK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. PINK.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PINK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PINK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PINK.CA Price Earnings VS Forward Price EarningsPINK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PINK.CA Per share dataPINK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PINK's earnings are expected to grow with 29.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.54%
EPS Next 3Y29.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PINK.CA Dividend Analysis

5.1 Amount

  • PINK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PINK.CA Fundamentals: All Metrics, Ratios and Statistics

PERIMETER MEDICAL IMAGING AI

TSX-V:PINK (4/10/2026, 7:00:00 PM)

0.315

-0.04 (-11.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-02
Earnings (Next)05-11
Inst Owners22.19%
Inst Owner ChangeN/A
Ins Owners21.86%
Ins Owner ChangeN/A
Market Cap41.30M
Revenue(TTM)N/A
Net Income(TTM)-14.35M
Analysts80
Price Target1.77 (461.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.13%
Min EPS beat(2)22.11%
Max EPS beat(2)28.15%
EPS beat(4)2
Avg EPS beat(4)-8.72%
Min EPS beat(4)-66.34%
Max EPS beat(4)28.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-36.12%
Min Revenue beat(2)-40.14%
Max Revenue beat(2)-32.1%
Revenue beat(4)2
Avg Revenue beat(4)22.41%
Min Revenue beat(4)-40.14%
Max Revenue beat(4)160.4%
Revenue beat(8)4
Avg Revenue beat(8)6.12%
Revenue beat(12)5
Avg Revenue beat(12)-5.78%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.31%
PT rev (3m)-6.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)22.24%
EPS NY rev (3m)22.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-5.64%
Revenue NY rev (3m)-5.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.85
P/FCF N/A
P/OCF N/A
P/B 8.58
P/tB 8.58
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.02
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -239.48%
ROE -412.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.01%
FCFM N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.17
Altman-Z -23.73
F-Score2
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y47.91%
EPS Next 2Y27.54%
EPS Next 3Y29.05%
EPS Next 5Y27.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%141.95%
Revenue Next Year158.26%
Revenue Next 2Y147.5%
Revenue Next 3Y106.85%
Revenue Next 5Y96.55%
EBIT growth 1Y20.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.83%
EBIT Next 3Y15.36%
EBIT Next 5Y24.37%
FCF growth 1Y-35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.75%
OCF growth 3YN/A
OCF growth 5YN/A

PERIMETER MEDICAL IMAGING AI / PINK.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PINK.CA.


Can you provide the valuation status for PERIMETER MEDICAL IMAGING AI?

ChartMill assigns a valuation rating of 1 / 10 to PERIMETER MEDICAL IMAGING AI (PINK.CA). This can be considered as Overvalued.


What is the profitability of PINK stock?

PERIMETER MEDICAL IMAGING AI (PINK.CA) has a profitability rating of 1 / 10.